Let's Make things Better
JNS: Drugs Controller General of India has issued permits to Scott-Edil Pharmacia Ltd in Himachal Pradesh and Skanttr Lifescience in Gujarat to produce and sell Prussian blue insoluble formulations. The WHO …
DCGI approves radiological and nuclear emergency drugs developed by DRDO Read More
JNS: Drugs Controller General of India (DCGI), India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat Biotech’s Covaxin, for children, aged …
Coronavirus vaccines for 5-12 years children Read More
JNS: Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group. With the emergency use approval to Corbevax, …
DCGI grants EUA to Corbevax for children between 12-18 years Read More
JNS: The subject expert committee (SEC) of Drugs controller General of India (DCGI) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on its intranasal vaccine. The company …
Bharat Biotech gets nod for Phase 3 trials of intranasal vaccine Read More
JNS: Drug Controller General of India (DCGI) has given nod to ZyCoV-D vaccine— indigenous developed Zydus Cadila COVID-19 vaccine for Emergency Use Authorization. In a statement Ministry of Science and …
DCGI approves DNA-based vaccine ZyCoV-D (three-dose vaccine) for Emergency Use Authorization Read More
JNS: The Drugs Controller General of India (DCGI), granted permission of the Emergency Use Authorisation (EUA) of Moderna’s COVID-19 vaccine in India on Tuesday. The DCGI, granted permission to Cipla (a …
Moderna gets government nod for EUA in India Read More
JNS: DRDO’s drug 2-Deoxy-D-Glucose is expected to be launched next week for the COVID patients, informed an official on Friday. The drug has been developed by the Defence Research and Development …
2-DG drug for treatment of COVID-19 patients to be launched next week Read More जेएनएस। ड्रग्स कंट्रोलर जनरल ऑफ इंडिया (DCGI) ने रक्षात्मक अनुसंधान और विकास संगठन (DRDO) द्वारा विकसित दवा को कोरोनोवायरस रोगियों के इलाज के लिए आपातकालीन उपयोग की मंजूरी दी है। …
डीसीजीआई ने डीआरडीओ की दवा को कोरोना मरीजों पर आपातकालीन उपयोग की मंजूरी दी Read More
JNS: India got third vaccine— Sputnik V, against Coronavirus, after Covishield (the Oxford-Astrazeneca vaccine manufactured by the Serum Institute of India) and Covaxin (manufactured by Bharat Biotech is developed in …
Sputnik V gets emergency use authorisation in India Read More JNS: Zydus Cadila Pharmaceuticals has received approval from the Drugs Controller General of India -DCGI to begin the phase-III clinical trials with its biological therapy Pegylated Interferon alpha-2b (PegiHep) in COVID-19 …
Zydus Cadila gets DCGI nod for phase-III clinical trials of COVID-19 vaccine Read More